相关实验视频

Updated: Jul 7, 2025

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

MiniMed 780G自动化胰岛素输送系统适应日常生活的重大变化:斋月期间真实世界用户的教训

Mohammed E Al-Sofiani^1,2, Goran Petrovski^3,4, Abdulrahman Al Shaikh⁵

¹Department of Internal Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Diabetes, obesity & metabolism

|December 27, 2023

概括

在斋月期间,MiniMed 780G自动化胰岛素输送系统有效地管理1型糖尿病. 这种系统证明了安全性和快速适应性,并保持了用户遵守快速的血糖控制.

科学领域:

内分泌学在内分泌学.
代谢疾病代谢疾病
医疗器械医疗器械

背景情况:

1型糖尿病的管理需要持续的葡萄糖监测和胰岛素输送.
斋月期间的生活方式的改变,如改变饮食模式和禁食,对血糖控制构成挑战.
自动胰岛素输送 (AID) 系统为在生活方式变化期间保持血糖目标提供了潜在的解决方案.

研究的目的:

评估MiniMed 780G AID系统在斋月期间1型糖尿病患者的有效性和安全性.
评估系统适应斋月固有的重大生活方式修改的能力.

主要方法:

对墨西哥湾地区MiniMed 780G用户的现实数据进行了回顾性分析.
纳入标准:在2022年斋月和之前/之后的几个月中,连续监测葡萄糖 (CGM) 数据≥10天.
每月汇总CGM终点,并根据白天时间 (白天/夜间) 分析;算法适应速度也被评估.

主要成果:

449名使用者保持了良好的血糖控制 (平均葡萄糖152.6 mg/dL,时间范围为70.7%).
尽管与非斋月月份有很小的差异,但血糖控制仍然具有临床意义.
白天没有降血糖的风险增加;时间范围在白天最高 (80.0%),而高血糖在晚上更高 (37.3%).

结论:

在斋月期间,MiniMed 780G系统对1型糖尿病患者来说是有效和安全的.
该系统迅速适应与斋月相关的重大生活方式变化.
现实世界的数据支持使用AID系统在间歇性禁食期间保持血糖控制.

关键词:

持续的葡萄糖监测 (CGM)胰岛素治疗中的胰岛素治疗.现实世界的证据.第1类糖尿病 1型糖尿病

更多相关视频

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device

Published on: January 26, 2010

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

相关概念视频

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Insulin Formulations: Types and Delivery

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...